XML 141 R95.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share Based Compensation (Schedule of CSARs Activity) (Details) (2013 AAG Incentive Award Plan [Member], USD $)
In Millions, except Share data in Thousands, unless otherwise specified
12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Cash Settled RSUs (CRSUs) [Member]
Dec. 31, 2012
Cash Settled RSUs (CRSUs) [Member]
Dec. 31, 2013
Cash-Settled Stock Appreciation Rights (CSARs) [Member]
Dec. 09, 2013
Cash-Settled Stock Appreciation Rights (CSARs) [Member]
Dec. 31, 2013
AA [Member]
Cash Settled RSUs (CRSUs) [Member]
Dec. 31, 2012
AA [Member]
Cash Settled RSUs (CRSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 626 320     291 0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]            
Assumed US Airways awards at December 9, 2013       2,888    
Granted     0      
Exercised     (23)      
Forfeited     0      
Expired     0      
Balance at December 31, 2013     2,865 2,888    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Exericse Price [Roll Forward]            
Assumed US Airways awards at December 9, 2013 - Weighted Average Exercise Price (in $ per share)       $ 6.25    
Granted - Weighted Average Exercise Price (in $ per share)     $ 0.00      
Exercised - Weighted Average Exercise Price (in $ per share)     $ 5.10      
Forfeited - Weighted Average Exercise Price (in $ per share)     $ 0.00      
Expired - Weighted Average Exercise Price (in $ per share)     $ 0.00      
Balance at December 31, 2013 - Weighted Average Exercise Price (in $ per share)     $ 6.26 $ 6.25    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Additional Disclosures [Abstract]            
Balance at December 31, 2013 - Weighted Average Remaining Contractual Term     3 years 3 months 18 days      
Balance at December 31, 2013 - Aggregate Intrinsic Value     $ 54      
Vested or expected to vest at December 31, 2013     2,864      
Exercisable at December 31, 2013     2,415      
Vested or expected to vest at December 31, 2013 - Weighted Average Exercise Price (in $ per share)     $ 6.26      
Exercisable at December 31, 2013 - Weighted Average Exercise Price (in $ per share)     $ 5.91      
Vested or expected to vest at December 31, 2013 - Weighted Average Remaining Contractual Term     3 years 3 months 18 days      
Exercisable at December 31, 2013 - Weighted Average Remaining Contractual Term     3 years 1 month 5 days      
Vested or expected to vest at December 31, 2013 - Aggregate Intrinsic Value     54      
Exercisable at December 31, 2013 - Aggregate Intrinsic Value     $ 47      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 25.25 $ 22.55     $ 25.25 $ 0.00
Granted 309       291  
Granted - Weighted average grant date fair value (in $ per share) $ 24.60       $ 24.60  
Vested and released (3)       0  
Vested and released - Weighted average grant date fair value (in $ per share) $ 25.25       $ 0.00  
Forfeited 0       0  
Forfeited - Weighted average grant date fair value (in $ per share) $ 0.00       $ 0.00